German vaccine manufacturer BioNTech, which rose to global prominence with its Covid-19 vaccine developed alongside Pfizer, ...

BioNTech SE plans to halt operations at several manufacturing sites, affecting as many as 1,860 jobs, due to dwindling demand ...

Five additional pivotal trials for pumitamig initiated during 2026 in collaboration with Bristol Myers SquibbOncology pipeline strength and ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The German company that pioneered one of the first mRNA coronavirus vaccines is halting production, handing the reins to ...

FRANKFURT, May 5 (Reuters) - Germany's BioNTech said on Tuesday it would close sites affecting up to 1,860 jobs and buy back ...

BioNTech SE (Nasdaq: BNTX, "BioNTech" or "the Company") will announce its financial results for the first quarter 2026 on Tuesday, May 5, 2026. Additionally ...

MAINZ, Germany, April 24, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data for selected assets from its diversified oncology pipeline, including mRNA cancer ...

MAINZ (Germany), May 5 (Bernama-dpa) -- German vaccine maker BioNTech, which rose to global prominence for its Covid-19 vaccine developed with Pfizer, plans to shut several production sites, affecting ...

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2026 on Tuesday, May 5, 2026. Additionally, the Company will host a conference call ...